Dr Susmita Chatterjee works at The George Institute for Global Health India as a Program Head of Health Economics. She has a PhD from the University of Calcutta, and is interested in investigating costing of health services, health financing, and economic evaluations. 

She has worked on several health economics projects in the areas of mental health, diabetes, cholera, typhoid, tuberculosis and immunization. She was the recipient of Asia Fellows Award in 2008; Indo-US public health fellowship in 2013 and Wellcome Trust / DBT India Alliance Intermediate fellowship in Clinical and Public Health in 2017. She was the Core Costing Working Group member for preparing the costing manual on provider payment mechanism – an initiative by the Joint Learning Network (JLN), USA and the economics group member of TB MAC (Tuberculosis Modelling and Analysis Consortium).

Before joining The George Institute India, she worked as Associate Professor at the Public Health Foundation of India (PHFI), New Delhi.

Bala Venkatesh is Director of Intensive care at the Wesley Hospital, Pre-Eminent specialist in Intensive Care Medicine at the Princess Alexandra Hospital, Brisbane, Professor of Intensive Care Medicine at the University of Queensland, and at the University of New South Wales, and Professorial Fellow at the George Institute for Global Health, Sydney Australia. He is the Chairman of the Queensland Health Statewide Sepsis Steering Committee. He is a Fellow of the Australian Academy of Health and Medical Sciences. 

He has completed Fellowship training in Internal Medicine, Anaesthesia and Intensive Care Medicine. He then undertook a research degree from the University of Birmingham, UK which led to the award of an MD. He pioneered the development of a continuous blood gas monitoring system which reached clinical application. 

He served as the President for the College of Intensive Care Medicine of Australia and New Zealand between 2014–2016. He led the international taskforce on gender equity in Intensive Care which influenced guidelines in the World Federation of Intensive Care. As President of the College of Intensive Care, he led the task force on bullying and discrimination which have informed College policy. 

He led the NHMRC funded multi-center international ADRENAL trial which is the largest septic shock trial to date. This was published in the New England Journal of Medicine and ranked in the top 12 articles of 2018. He has served on several Data Safety Monitoring Committees and on the Management committee of RCTs in sepsis. His research interests include glucocorticoid physiology in critical illness including the development of the idea of the "sick euadrenal state," sepsis and vitamin D in critical illness. 

In 2020, following the Covid-19 pandemic, he contributed to the REMAP-CAP steroid trial design and development and was on its writing committee recently reported in JAMA, which influenced guideline development. He was instrumental in the development of the George Institute's Covid-19 research program in India and played a key role in the set up of the COVID Steroid 2 trial in India which was also published in JAMA. He is currently investigating the role of fludrocortisone in septic shock. 

He has published more than 250 papers, 40 book chapters, and edited 2 books. He has supervised 8 PhD students. He is now a Level 3 NHMRC Investigator Fellow. 

Cat is an NIHR Clinical Lecturer in Public Health Medicine at the Institute of Health Informatics at UCL and specialty registrar (ST5) in London. She is also an Honorary Lecturer at King's College London and The George Institute for Global Health, UK, in partnership with Imperial College London. She is also an NIHR ARC NWL Improvement Leader Fellow in the 2023 cohort.

She completed medical school in Portugal in 2012 and moved to the UK inspired by her dream of working for the NHS. Although she initially started her specialty training in Cardiothoracic Surgery in Manchester, her long-term illness forced a sharp turn in her career. She completed her DPhil in the University of Oxford, simultaneously with an MSc in Public Health at King's College London. She started her specialty training in Public Health in August 2020 as NIHR Academic Clinical Fellow at King's College London.

She has an insatiable curiosity and broad research interests, which explains why she has been involved in many different types of research over the years. She has finally committed to her two passions: climate & air pollution and health and gender inequalities. She co-leads the implementation of the Climate & Health Strategy with the Climate & Health Committee of the Faculty of Public Health; is chair of the Specialty Registrars’ Committee, which represents registrars nationwide in the Faculty of Public Health; and co-chair of the Academic Public Health Special Interest Group, which she co-founded in 2022. In addition, she is committed to Public Health education and has been actively teaching in the MPH at King's College London and University College London since 2020. She is also leading the European course on climate & health organised by the Association of Schools of Public Health in the European Region (ASPHER), as she is member of the working group on climate and health.

Professor Clare Arnott is Director of the Cardiovascular Program at The George Institute for Global Health and Associate Professor in Medicine at UNSW Sydney. 

Prof Arnott’s research focuses on women’s heart disease, heart failure, cardiovascular imaging, and cardio-kidney-metabolic (CKM) disease. Her work has significantly influenced national health policy and clinical management. 

As an experienced clinical trialist and the recipient of $28 million in research funding, Prof Arnott is an expert in investigating novel cardiometabolic treatments and pregnancy-related cardiovascular diseases including pre-eclampsia and pulmonary hypertension. 

She is also Pagent Director of Heart Lung Clinical Research at St Vincent's Hospital, Sydney, Director and Founder of the Women’s Heart Clinic at Royal Prince Alfred Hospital, and Senior Staff Specialist Cardiologist at St Vincent’s Hospital and Royal Prince Alfred Hospital, Sydney.

Prof Arnott is a Fellow of the Cardiac Society of Australia and New Zealand and the European Society of Cardiology, and member of the ANZACT Steering Committee, as well as serving on the editorial board of Heart, Lung and Circulation. 

Julie Brown heads the Injury Program at The George Institute for Global Health, Australia and is a Professor, School of Population Health, UNSW Sydney. She works across the continuum of the public health model from defining problems, identifying risk and protective factors, developing and testing interventions to monitoring and evaluating the implementation of interventions designed to reduce the burden of injury, and has demonstrated expertise in multi-disciplinary research methods. Her career vision is to reduce the health burden attributable to injury by delivering tangible ways to prevent road crash-related injury and unintentional injury more broadly. Prior to completing her PhD at UNSW in 2008, she worked for over 20 years in vehicle and equipment safety research and policy development for the NSW government. Insight into research needs for regulatory and policy development from this experience continues to frame her research.

Professor Michael Kidd AO FAHMS is the Chief Medical Officer for Australia. He also holds a joint appointment as the foundation Director of the International Centre for Future Health Systems at the University of New South Wales in Sydney, Australia, and as Professor of Global Primary Care and Future Health Systems at the Nuffield Department of Primary Care Health Sciences at the University of Oxford in the United Kingdom, where he is also a Senior Research Fellow of Green Templeton College, a Fellow of Kellogg College, and co-director of the World Health Organization Collaborating Centre on Primary Health Care.

He is a Non-Executive Director of Kaleido Health Centre, a member of the Avant Foundation Board, and Patron of the Australian General Practice Research Foundation, General Practice Student Network, and General Practice Registrars Association. He is a past president of both The Royal Australian College of General Practitioners, and the World Organization of Family Doctors.

Michael joined the Board in December 2023.